World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
125
Citations
97998
World Ranking
3010
National Ranking
1665

Overview

Thomas A. Medsger is affiliated with the University of Pittsburgh in the United States. Their research primarily focuses on medicine, with significant contributions in biochemistry, genetics, and molecular biology. Their work spans multiple subfields including pathology and forensic medicine, pulmonary and respiratory medicine, molecular biology, immunology, and dermatology.

The scientist's main research topics include systemic sclerosis and related diseases, interstitial lung diseases and idiopathic pulmonary fibrosis, connective tissue growth factor research, mast cells and histamine, dermatologic treatments and research, pulmonary hypertension research and treatments, and Kruppel-like factors research.

Frequent coauthors collaborating with Thomas A. Medsger are:

  • Robyn T. Domsic
  • Virginia Steen
  • Maureen Laffoon
  • Dinesh Khanna
  • Robert Lafyatis

Common publication venues where they have contributed include:

  • American Journal of Respiratory and Critical Care Medicine
  • Lara D. Veeken
  • Journal of Scleroderma and Related Disorders
  • Annals of the Rheumatic Diseases
  • Arthritis & Rheumatology

Recent publications by Thomas A. Medsger reflect engagement with systemic sclerosis and pulmonary conditions:

  • Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial (2021) published in American Journal of Respiratory and Critical Care Medicine
  • Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis (2021) published in Annals of the Rheumatic Diseases
  • Development of Pulmonary Hypertension in Over One-Third of Patients With Th/To Antibody-Positive Scleroderma in Long-Term Follow-Up (2022) published in Arthritis & Rheumatology
  • Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design (2021) published in Lara D. Veeken
  • A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials (2022) published in Lara D. Veeken

Best Publications

  • The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

    Frank C. Arnett;Steven M. Edworthy;Daniel A. Bloch;Dennis J. Mcshane

  • Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee

    R. Altman;E. Asch;D. Bloch;G. Bole

  • Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

    LeRoy Ec;Black C;Fleischmajer R;Jablonska S

  • Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

    C Leroy;RD Altman;J.B. Kirsner

  • The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip.

    R. Altman;G. Alarcón;D. Appelrouth;D. Bloch

  • Age-specific Incidence Rates of Myocardial Infarction and Angina in Women With Systemic Lupus Erythematosus: Comparison With the Framingham Study

    Susan Manzi;Elaine N Meilahn;Joan E Rairie;Claudia G. Conte

  • Changes in causes of death in systemic sclerosis, 1972-2002.

    Virginia D Steen;Thomas A Medsger

  • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

    David B. Badesch;Victor F. Tapson;Michael D. McGoon;Bruce H. Brundage

  • Severe organ involvement in systemic sclerosis with diffuse scleroderma.

    Virginia D. Steen;Thomas A. Medsger

  • Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

    Virginia D. Steen;Donald L. Powell;Thomas A. Medsger

  • Severe restrictive lung disease in systemic sclerosis

    Virginia D. Steen;Claudia Conte;Gregory R. Owens;Thomas A. Medsger

  • Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

    Virginia Steen;Virginia Steen;Thomas A. Medsger

  • The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time.

    Virginia D. Steen;Thomas A. Medsger

  • Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis

    Virginia D. Steen;Thomas A. Medsger

  • Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

    Marco Matucci-Cerinic;Christopher P Denton;Daniel E Furst;Maureen D Mayes

  • Mortality in systemic sclerosis: An international meta-analysis of individual patient data

    John P.A. Ioannidis;John P.A. Ioannidis;Panayiotis G. Vlachoyiannopoulos;Anna Bettina Haidich;Thomas A. Medsger

  • Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.

    Virginia D. Steen;Joseph P. Costantino;Alvin P. Shapiro;Thomas A. Medsger

  • A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis.

    Ellen M. Ginzler;Ellen M. Ginzler;Herbert S. Diamond;Max Weiner;Michael Schlesinger

  • Incidence of systemic lupus erythematosus race and gender differences

    Daniel J. Mccarty;Daniel J. Mccarty;Susan Manzi;Thomas A. Medsger;Rosalind Ramsey‐Goldman

  • Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis.

    Angela M. Stupi;Virginia D. Steen;Gregory R. Owens;E. Leon Barnes

Frequent Co-Authors

Virginia D. Steen
Virginia D. Steen Georgetown University
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
John Varga
John Varga University of Michigan–Ann Arbor
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Masataka Kuwana
Masataka Kuwana Nippon Medical School
Fredrick M. Wigley
Fredrick M. Wigley Johns Hopkins University
Philip J. Clements
Philip J. Clements University of California, Los Angeles
Michael H. Weisman
Michael H. Weisman Cedars-Sinai Medical Center
Larry W. Moreland
Larry W. Moreland University of Colorado Anschutz Medical Campus

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to various online degrees and alternative career pathways in healthcare. For high school students interested in starting early, reviewing the best online schools for high school students can offer specialized health-related courses, providing a head start in the field.

Not all healthcare careers require a medical degree. For example, those interested in administrative roles can pursue medical billing and coding online. This pathway offers flexible study options and prepares graduates for in-demand positions in clinics and hospitals.

Nursing remains one of the most popular and accessible healthcare professions. Prospective nurses can search for affordable online fnp programs to advance their credentials, or explore what is the cheapest online college for nursing? to find budget-friendly educational options.

These online healthcare programs offer flexible pathways to enter or advance in the medical field, making a variety of roles accessible—even for those who may not wish to pursue a traditional medical degree.

Best Scientists Citing Thomas A. Medsger

Trending Scientists